Progress Perspective Treatment Lung (21 results)
- Hardcover
Seller: S.C. Sumner, Venice, FL, U.S.A.S.C. Sumner
Contact seller2-star sellerCondition: Used - Very good
£ 31.10
Free ShippingShips within U.S.A.Quantity: 1 available
Hard Cover. Condition: Very Good. No ownership markings; a bit of staining to rear endpapers.
- Hardcover
Seller: Universitätsbuchhandlung Herta Hold GmbH, Berlin, , GermanyUniversitätsbuchhandlung Herta Hold GmbH
Contact seller4-star sellerCondition: Used
£ 21.44
£ 26.02 shippingShips from Germany to U.S.A.Quantity: 1 available
1999. 19 x 27 cm. X, 280 S. X, 280 p. 3 illus. in color. hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, dah (Medical Radiology; Radiation Oncology). Sprache: Englisch.
Published by Springer, 1999
- Hardcover
Seller: Antiquariat Knacke, Berlin, , GermanyAntiquariat Knacke
Contact seller4-star sellerCondition: Used
£ 22.33
£ 10.41 shippingShips from Germany to U.S.A.Quantity: 2 available
Sprache: Englisch Pappband. Noch eingeschweißtes Exemplar.
- Hardcover
Seller: Roland Antiquariat UG haftungsbeschränkt, Weinheim, GermanyRoland Antiquariat UG haftungsbeschränkt
Contact seller5-star sellerCondition: Used
£ 67.80
£ 36.43 shippingShips from Germany to U.S.A.Quantity: 1 available
Hardcover: 19.3 x 0 x 27 cm. 1999. 290 p. Unread book. Like new! 9783540625483 Sprache: Englisch Gewicht in Gramm: 939.
- Hardcover
Seller: Basi6 International, Irving, TX, U.S.A.Basi6 International
Contact seller5-star sellerCondition: New
£ 115.56
Free ShippingShips within U.S.A.Quantity: 1 available
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
- Softcover
Seller: preigu, Osnabrück, Germanypreigu
Contact seller5-star sellerCondition: New
£ 125.06
£ 60.71 shippingShips from Germany to U.S.A.Quantity: 5 available
Taschenbuch. Condition: Neu. Progress and Perspective in the Treatment of Lung Cancer | Paul Van Houtte (u. a.) | Taschenbuch | Medical Radiology | x | Englisch | 2011 | Springer | EAN 9783642641404 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[do…t]com | Anbieter: preigu.
- Softcover
Seller: preigu, Osnabrück, Germanypreigu
Contact seller5-star sellerCondition: New
£ 126.13
£ 60.71 shippingShips from Germany to U.S.A.Quantity: 5 available
Taschenbuch. Condition: Neu. Progress and Perspective in the Treatment of Lung Cancer | Paul Van Houtte (u. a.) | Taschenbuch | Medical Radiology | x | Englisch | 1999 | Springer | EAN 9783540625483 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[do…t]com | Anbieter: preigu.
- Softcover
Seller: AHA-BUCH GmbH, Einbeck, GermanyAHA-BUCH GmbH
Contact seller5-star sellerCondition: New
£ 143.36
£ 54.78 shippingShips from Germany to U.S.A.Quantity: 1 available
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Lung cancer is not a single disease process but is a group of biologically variable diseases. Therefore, accurate and complete diagnosis along with complete workup of the patient prior to decision-making in treatment is essential to devise the most… appropriate treatment strategy. In North America adenocarcinoma of the lung now accounts for about 40% of all lung cancers and stage for stage these tumors have a poorer prognosis than squamous cell cancers of the lung. Many prognostic indicators have been identified such as genetic markers and neuroen docrine differentiation, which have important roles to play in identifying the patients who would benefit most from active treatment. Screening and early detection have been thought to be sine qua non in early diagnosis of lung cancer. However, a number of controlled trials assessing the value of annual screening for lung cancer have demonstrated in some studies that chest X-rays and/or cytology screening may improve stage distribution, resectability, survival, and fatality but has not shown an impact on disease-specific mortality rates. The Mayo Clinic lung project compar ing quarterly chest X-rays and sputum cytology with routine care in more than 10 000 male smokers indicated that 5-year survival following treatment in the screened patients was better than rates in contemporary clinical practice. However, arguments have been ad vanced as to factors that might have biased the clinical benefits. Other trials are currently under way to deal with this issue along with new molecular markers that may enhance sputum sensitivity.
- Softcover
Seller: AHA-BUCH GmbH, Einbeck, GermanyAHA-BUCH GmbH
Contact seller5-star sellerCondition: New
£ 143.36
£ 54.85 shippingShips from Germany to U.S.A.Quantity: 1 available
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Lung cancer is not a single disease process but is a group of biologically variable diseases. Therefore, accurate and complete diagnosis along with complete workup of the patient prior to decision-making in treatment is essential to devise the most… appropriate treatment strategy. In North America adenocarcinoma of the lung now accounts for about 40% of all lung cancers and stage for stage these tumors have a poorer prognosis than squamous cell cancers of the lung. Many prognostic indicators have been identified such as genetic markers and neuroen docrine differentiation, which have important roles to play in identifying the patients who would benefit most from active treatment. Screening and early detection have been thought to be sine qua non in early diagnosis of lung cancer. However, a number of controlled trials assessing the value of annual screening for lung cancer have demonstrated in some studies that chest X-rays and/or cytology screening may improve stage distribution, resectability, survival, and fatality but has not shown an impact on disease-specific mortality rates. The Mayo Clinic lung project compar ing quarterly chest X-rays and sputum cytology with routine care in more than 10 000 male smokers indicated that 5-year survival following treatment in the screened patients was better than rates in contemporary clinical practice. However, arguments have been ad vanced as to factors that might have biased the clinical benefits. Other trials are currently under way to deal with this issue along with new molecular markers that may enhance sputum sensitivity.
- Softcover
Seller: Books Puddle, New York, NY, U.S.A.Books Puddle
Contact seller4-star sellerCondition: New
£ 209.51
£ 3.02 shippingShips within U.S.A.Quantity: 4 available
Condition: New. pp. x + 280 Softcover Reprint of the Original 1st Edition 1999.
- Softcover
Seller: Revaluation Books, Exeter, , United KingdomRevaluation Books
Contact seller5-star sellerCondition: New
£ 207.96
£ 12.50 shippingShips from United Kingdom to U.S.A.Quantity: 1 available
Paperback. Condition: Brand New. reprint edition. 290 pages. 10.63x0.70x7.60 inches. In Stock.
- Softcover
Seller: Mispah books, Redhill, SURRE, United KingdomMispah books
Contact seller4-star sellerCondition: Used - As new
£ 219.00
£ 25.00 shippingShips from United Kingdom to U.S.A.Quantity: 1 available
Paperback. Condition: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
- Softcover
- Print on Demand
Seller: Brook Bookstore On Demand, Napoli, NA, ItalyBrook Bookstore On Demand
Contact seller3-star sellerCondition: New
£ 112.79
£ 5.90 shippingShips from Italy to U.S.A.Quantity: Over 20 available
Condition: new. Questo è un articolo print on demand.
- Softcover
- Print on Demand
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, , GermanyBuchWeltWeit Ludwig Meier e.K.
Contact seller5-star sellerCondition: New
£ 143.36
£ 19.95 shippingShips from Germany to U.S.A.Quantity: 2 available
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Lung cancer is not a single disease process but is a group of biologically variable diseases. Therefore, accurate and complete diagnosis along with complete workup of the patient prior to decision-making in treatment is essential to… devise the most appropriate treatment strategy. In North America adenocarcinoma of the lung now accounts for about 40% of all lung cancers and stage for stage these tumors have a poorer prognosis than squamous cell cancers of the lung. Many prognostic indicators have been identified such as genetic markers and neuroen docrine differentiation, which have important roles to play in identifying the patients who would benefit most from active treatment. Screening and early detection have been thought to be sine qua non in early diagnosis of lung cancer. However, a number of controlled trials assessing the value of annual screening for lung cancer have demonstrated in some studies that chest X-rays and/or cytology screening may improve stage distribution, resectability, survival, and fatality but has not shown an impact on disease-specific mortality rates. The Mayo Clinic lung project compar ing quarterly chest X-rays and sputum cytology with routine care in more than 10 000 male smokers indicated that 5-year survival following treatment in the screened patients was better than rates in contemporary clinical practice. However, arguments have been ad vanced as to factors that might have biased the clinical benefits. Other trials are currently under way to deal with this issue along with new molecular markers that may enhance sputum sensitivity. 296 pp. Englisch.
- Softcover
- Print on Demand
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, , GermanyBuchWeltWeit Ludwig Meier e.K.
Contact seller5-star sellerCondition: New
£ 143.36
£ 19.95 shippingShips from Germany to U.S.A.Quantity: 2 available
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -'This volume provides a comprehensive account of the progress that has been made in the treatment of lung cancer. The various therapeutic approaches are documented and appraised, with particular emphasis being placed on the benefits… of a multimodality strategy. A balance is sought between US and European perspectives, and all of the authors are recognized experts in the field. 296 pp. Englisch.
- Softcover
- Print on Demand
Seller: moluna, Greven, , Germanymoluna
Contact seller5-star sellerCondition: New
£ 121.62
£ 42.49 shippingShips from Germany to U.S.A.Quantity: Over 20 available
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. With contributions by numerous experts|Comprehensive account of the progress in the treatment of lung cancerVarious therapeutic approaches are documented and appraised, with particular emphasis being placed on the ben…efits of a multimodality strategy.
- Hardcover
- Print on Demand
Seller: moluna, Greven, , Germanymoluna
Contact seller5-star sellerCondition: New
£ 121.62
£ 42.49 shippingShips from Germany to U.S.A.Quantity: Over 20 available
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. With contributions by numerous experts|Comprehensive account of the progress in the treatment of lung cancerVarious therapeutic approaches are documented and appraised, with particular emphasis being placed on the ben…efits of a multimodality strategy.
- Softcover
- Print on Demand
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germanybuchversandmimpf2000
Contact seller5-star sellerCondition: New
£ 143.36
£ 52.04 shippingShips from Germany to U.S.A.Quantity: 1 available
Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This volume provides a comprehensive account of the progress that has been made in the treatment of lung cancer. The various therapeutic approaches are documented and appraised, with particular emphasis being placed on the benefits of a… multimodality strategy. A balance is sought between US and European perspectives, and all of the authors are recognized experts in the field.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 296 pp. Englisch.
- Softcover
- Print on Demand
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germanybuchversandmimpf2000
Contact seller5-star sellerCondition: New
£ 143.36
£ 52.04 shippingShips from Germany to U.S.A.Quantity: 1 available
Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This volume provides a comprehensive account of the progress that has been made in the treatment of lung cancer. The various therapeutic approaches are documented and appraised, with particular emphasis being placed on the benefits of a… multimodality strategy. A balance is sought between US and European perspectives, and all of the authors are recognized experts in the field.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 296 pp. Englisch.
- Softcover
- Print on Demand
Seller: Majestic Books, Hounslow, , United KingdomMajestic Books
Contact seller4-star sellerCondition: New
£ 219.31
£ 6.50 shippingShips from United Kingdom to U.S.A.Quantity: 4 available
Condition: New. Print on Demand pp. x + 280 56 Figures.
- Softcover
- Print on Demand
Seller: Biblios, frankfurt am main, HESSE, GermanyBiblios
Contact seller4-star sellerCondition: New
£ 225.37
£ 8.63 shippingShips from Germany to U.S.A.Quantity: 4 available
Condition: New. PRINT ON DEMAND pp. x + 280.
